Abstract
Background/Aims: Obesity leads to increased risk of thromboembolic events in adults, but few studies have addressed the relationship between obesity and thrombogenic risk during childhood. The aim of this study was to evaluate the prothrombotic state of obese children in comparison with healthy children. Methods: Thrombin generation, fibrinogen, and D-dimer levels, along with metabolic parameters, were measured in 72 prepubertal children, of which 47 were obese and 25 eutrophic. Results: A significant increase in thrombin generation, fibrinogen, and dyslipidemia was found among obese patients. Conclusion: A prothrombotic state develops in childhood obesity during the prepubertal phase.
References
1.
Ng
M
, Fleming
T
, Robinson
M
, Thomson
B
, Graetz
N
, Margono
C
, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013
. Lancet
. 2014
;384
(9945
):766
–81
.2.
Obesity: preventing and managing the global epidemic. Report of a WHO consultation
. World Health Organ Tech Rep Ser
. 2000
;894
:i
–xii
3.
Yusuf
S
, Hawken
S
, Ounpuu
S
, Bautista
L
, Franzosi
MG
, Commerford
P
, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
. Lancet
. 2005
;366
(9497
):1640
–9
.4.
Samad
F
, Ruf
W
. Inflammation, obesity, and thrombosis
. Blood
. 2013
;122
(20
):3415
–22
.5.
Stein
PD
, Goldman
J
. Obesity and thromboembolic disease
. Clin Chest Med
. 2009
;30
(3
):489
–viii
.6.
Stein
PD
, Beemath
A
, Olson
RE
. Obesity as a risk factor in venous thromboembolism
. Am J Med
. 2005
;118
(9
):978
–80
.7.
RF F. Fisiologia da coagulação, anticoagulação e fibrinólise revistas usp2001.
8.
Orkin
SH
, Fisher
DE
, Ginsburg
D
, Look
AT
, Lux
SE
, Nathan
DG
. Nathan and Oski’s hematology and oncology of infancy and childhood
; 2015
.9.
Hafez
M
, El-Masry
S
, Musa
N
, Fathy
M
, Hassan
M
, Hassan
N
, et al. Relationship between visceral obesity and plasma fibrinogen in obese children
. J Pediatr Endocrinol Metab
. 2016
;29
(3
):289
–96
.10.
Balagopal
PB
, de Ferranti
SD
, Cook
S
, Daniels
SR
, Gidding
SS
, Hayman
LL
, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American heart association
. Circulation
. 2011
;123
(23
):2749
–69
.11.
Ninivaggi
M
, Apitz-Castro
R
, Dargaud
Y
, de Laat
B
, Hemker
HC
, Lindhout
T
. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay
. Clin Chem
. 2012
;58
(8
):1252
–9
.12.
Al Dieri
R
, de Laat
B
, Hemker
HC
. Thrombin generation: what have we learned
. Blood Rev
. 2012
;26
(5
):197
–203
.13.
Brummel-Ziedins
K
, Vossen
CY
, Rosendaal
FR
, Umezaki
K
, Mann
KG
. The plasma hemostatic proteome: thrombin generation in healthy individuals
. J Thromb Haemost
. 2005
;3
(7
):1472
–81
.14.
Brummel-Ziedins
KE
, Everse
SJ
, Mann
KG
, Orfeo
T
. Modeling thrombin generation: plasma composition based approach
. J Thromb Thrombolysis
. 2014
;37
(1
):32
–44
.15.
Tripodi
A
. Thrombin generation assay and its application in the clinical laboratory
. Clin Chem
. 2016
;62
(5
):699
–707
.16.
Cimenti
C
, Mangge
H
, Haidl
H
, Zach
D
, Muntean
W
. Thrombin generation in severely obese children
. J Thromb Haemost
. 2006
;4
:1834
–6
.17.
Siklar
Z
, Öçal
G
, Berberoğlu
M
, Hacihamdioğlu
B
, Savas Erdeve
S
, Eğin
Y
, et al. Evaluation of hypercoagulability in obese children with thrombin generation test and microparticle release: effect of metabolic parameters
. Clin Appl Thromb Hemost
. 2011
;17
(6
):585
–9
.18.
Fritsch
P
, Kleber
M
, Rosenkranz
A
, Fritsch
M
, Muntean
W
, Mangge
H
, et al. Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels
. Atherosclerosis
. 2010
;212
(2
):650
–5
.© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
You do not currently have access to this content.
